Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2

Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
chemotherapy
escc, tislelizumab, chemotherapy, becotatug vedotin, egfr adc, pd-1 inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 148778
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.